Please find attached Audited Financial Results for the quarter and year ended 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Veerhealth Care Ltd reported strong revenue growth for FY2026 with total revenue of Rs 3,328.61 lakhs, up 86% from Rs 1,788.93 lakhs in FY2025. Revenue from operations grew 92.6% to Rs 3,248.45 lakhs. Profit after tax stood at Rs 54.40 lakhs, a 39% increase from Rs 39.15 lakhs in the previous year. EPS improved to Rs 0.27 from Rs 0.20. The Board did not recommend any dividend to conserve company resources. EBITDA margin compressed from approximately 10% to 8.9% as expenses grew faster than revenue. Trade receivables nearly tripled to Rs 973.32 lakhs, indicating significant increase in credit sales. The statutory auditor issued an unmodified (clean) opinion on the financial results.
The company delivered robust top-line growth exceeding 90%, but margin compression and rising receivables warrant caution. No dividend and working capital concerns may weigh on investor sentiment despite healthy profit growth.